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Abstract: A series of substituted 2-phenylquinoxaline ligands have been explored to 
finely tune the visible emission properties of a corresponding set of cationic, 
cyclometalated iridium(III) complexes. The electronic and redox properties of the 
complexes were investigated using experimental (including time-resolved 
luminescence and transient absorption spectroscopy) and theoretical methods. The 
complexes display absorption and phosphorescent emission in the visible region 
attributed to MLCT transitions. The different substitution patterns of the ligands 
induce variations in these parameters. TD-DFT studies support these assignments 
and show that there is likely to be a strong spin-forbidden contribution to the visible 
absorption bands at 500-600 nm. Calculation also reliably predict the magnitude and 
trends in triplet emitting wavelengths for the series of complexes. The complexes 
were assessed as potential sensitizers in triplet-triplet annihilation upconversion 
experiments using 9,10-diphenylanthracene as the acceptor, with the methylated 
variants performing especially well with impressive upconversion quantum yields up 
to 39.3 %. 
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Introduction 
Photoactive metal coordination compounds continue to find broadening application in 
several disciplines such as electroluminescence, photovoltaics, photocatalysis, and 
bioimaging. In particular, organometallic Ir(III) complexes are extremely attractive as 
a wide range of ligand architectures exist and can be developed to allow tuning of the 
excited state properties of such complexes.1 A more recent development in their 
potential application is in the field of triplet-triplet annihilation (TTA) upconversion2 
where such species, through a limited number of studies,3 appear to be well suited to 
use as sensitizers which stimulate fluorescence from an appropriate annihilator 
acceptor molecule. TTA upconversion is of great interest due to the benefits that such 
processes can provide to the disciplines outlined earlier. A small number of reports 
have described the use of Ir(III) complexes for TTA upconversion4 with the best 
performing to date being pyrene-conjugated species of the type [Ir(ppy)2(L)]PF6 which 
demonstrated highly efficient upconversion quantum yields of up to 31.6 % (the 
highest value yet reported).5 Typically, the sensitizer should possess good molar 
absorption at the wavelength of excitation and a long triplet lifetime.6 
 Our own work into luminescent Ir(III) complexes has included the development 
of low energy emitting species that luminesce in the red part of the visible spectrum. 
The requisite cyclometalating ligands are based upon core ligand structures of 2-
phenylquinoline7 or 2-phenylquinoxaline8 and these can provide interesting species 
with related pyrene derivatives also showing capability as potent photooxidation 
sensitizers.9 Other studies have reported extending the emission wavelengths of Ir(III) 
complexes into the NIR region.10 
 In the current work, we have focused upon the development of poly-substituted 
quinoxaline ligands to tune the emission of a new series of cationic cyclometalated 
Ir(III) complexes. The ability to finely tune the excited state character and energy of 
the complex is essential when considering applications such as TTA upconversion. 
The structural and spectroscopic characterisation of these complexes together with 
detailed theoretical analysis has provided further insight into the species and their 
application to TTA upconversion. We now report a world-leading TTA upconversion 
efficiency of 39.3% from one of the iridium complexes within our series of newly 
synthesized phosphors. 
 
	 3	
Results and Discussion 
All ligands (Scheme 1) were synthesised by heating the required phenyldiamine with 
benzil or 1-phenyl-1,2-propanedione in ethanol in the presence of acetic acid. The 
ligands were reacted with iridium trichloride to generate the chloro-bridged dimetallic 
[Ir(L)2-μ-Cl]2 species,11 which were subsequently reacted with 2,2’-bipyridine in 2-
ethoxyethanol at 120° to yield the corresponding monometallic species 
[Ir(L)2(bpy)]PF6 following precipitation with NH4PF6 (sat. aq.). These reaction 
conditions are known to favour the cis-C,C and trans-N,N coordination mode for the 
cyclometalating ligand at Ir(III) and have been supported by structural data.12 Other 
studies have shown that the mutual cis-C,C and cis-N,N arrangement of certain 
cyclometalating ligands can be achieved using different reaction conditions.13 If 
required, further purification was achieved using column chromatography (silica) by 
eluting a major red band with DCM/MeOH (95/5). All complexes (Scheme 1) were 
isolated as reddish brown air-stable solids. L1 has been previously reported, but all 
characterisation data are included in the Experimental section for convenience and 
comparison.14 
 The complexes were characterized using multinuclear NMR, IR, UV-vis., 
transient absorption and luminescence spectroscopies, as well as HRMS, cyclic 
voltammetry and X-ray diffraction. 1H NMR spectra provided clear evidence for the 
formation of the complexes with characteristic shifts in the various resonances 
associated with the quinoxaline ligands. In particular, the proton adjacent to the 
cyclometalated carbon was shifted upfield in all cases indicative of the shielding effect 
of coordination to iridium(III). For [Ir(L1)2(bpy)]PF6, [Ir(L2)2(bpy)]PF6 and 
[Ir(L3)2(bpy)]PF6 the methyl resonance(s) were shifted away from the corresponding 
free ligand values. 19F{1H} NMR spectroscopy was used to analyse [Ir(L4)2(bpy)]PF6 
and [Ir(L7)2(bpy)]PF6 and revealed (Table 1) observable differences in the 19F 
resonances in the spectra. Firstly, for the ligand-based fluorines, typical shifts were 
observed around -131 ppm; these were subtly shifted upon coordination when 
compared to the free ligands. A loss of chemical equivalence in the L7 fluorines was 
anticipated upon cyclometalation via the expected coordination mode, and this 
manifested in a 3JFF coupling of around 22 Hz.15 Both complexes showed an additional 
chemical shift ca. -73 ppm which is assigned to the non-coordinating 
hexafluorophosphate. Examples of obtained NMR spectra are shown in the ESI 
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Figures S1-S5. The observations from the NMR data are consistent with the presence 
of a single isomer of complex in each case. 
 
<Scheme 1> 
 
HRMS data were obtained for each of the complexes confirming the proposed 
formulations and showing the expected isotopic distributions in each case; the dichloro 
species, in particular, produced distinct spectra. Supporting IR data principally 
indicated the presence of the coordinated ligands in each case and the 
hexafluorophosphate counter anion at ca. 840 cm-1. 
 
Table	1.	19F{1H}	NMR	chemical	shift	and	coupling	constant	values	for	the	fluorinated	ligands	
and	complexes.	
	
Compound[a] Ligand d (3JFF) / ppm PF6- d (1JFP) / ppm 
L4 -130.4 (d, 21 Hz),  
-131.2 (d, 21 Hz) 
 
[Ir(L4)2(bpy)]PF6 -131.7 (d, 22 Hz),  
-133.7(d, 22 Hz) 
-72.6 (d, 712 Hz) 
L7 -129.9 (s)  
[Ir(L7)2(bpy)]PF6 -130.3 (d, 22 Hz),  
-132.7 (d, 22 Hz) 
-72.6 (d, 700 Hz) 
	
 
X-ray Crystallography 
 
X-ray quality single crystals were obtained for two of the methylated species 
[Ir(L2)2(bpy)]PF6, [Ir(L5)2(bpy)]PF6 and the difluoro variant [Ir(L7)2(bpy)]PF6 via a 
vapour diffusion methodology (diethyl ether into acetonitrile solutions). Data collection 
parameters are reported in ESI, Table S1, whilst key bond length/angle data are 
shown in ESI, Tables S2 and S3. Each complex adopts a distorted octahedral 
geometry at Ir(III) with substituted quinoxaline ligands chelating in a N^C fashion 
(Figure 1). The obtained structures confirm the expected cis-C,C and trans-N,N 
arrangements of the cyclometalating ligands that are retained irrespective of the 
quinoxaline ligand substitution. The observation support previous assertions about the 
stronger trans influence of the phenyl group over nitrogen heterocycle donors.16 Bond 
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lengths to Ir(III) lie in the typical range expected for such species. Additional packing 
diagrams are shown in the ESI showing that intermolecular pi-pi contacts are present 
between phenyl rings on the quinoxaline ligands of neighbouring complexes. 
 Figure 2 shows a comparison of the experimental crystal structure of 
[Ir(L5)2(bpy)]PF6 with the computationally optimized structure. The figure 
demonstrates that the computational method chosen serves to adequately reproduce 
the crystal structure (RMSD < 0.5 Å) with the majority of the discrepancy being 
introduced by the position of the methyl substituent groups, which likely derives from 
a combination of errors in crystallography and DFT. This is to be expected given the 
low frequency vibrational motions associated with both the flexing and torsional 
motions of these methyl groups. Some discrepancy is observed with the bipyridine 
position, such that the computed geometry is closer to C2 symmetry. 
 
<Figure 1> 
 
<Figure 2> 
 
Electronic properties of the complexes 
The UV-vis. absorption properties of the complexes were determined using chloroform 
solutions. Between 260-400 nm the complexes show a composite of high probability 
transitions that overlap with one another. The bands are generally ascribed to the 
different ligand-centred transitions relating to the coordinated quinoxaline and 
bipyridine ligands. They are likely to comprise of various p®p* transitions with the 
possibility of weaker n®p* arising from the heterocyclic quinoxaline core. The spectra 
show a strong feature at 400-450 nm, and a weaker, broad, lower energy band 
peaking at 474-498 nm (the associated molar absorption coefficients are ca. 5 ´ 103 
M-1cm-1); transitions which are likely to possess some MLCT character. The 
positioning of these bands are clearly dependent upon the substitution of the 
cyclometalated quinoxaline ligand: the halogenated complexes show the longest 
wavelength values whilst the methylated analogues are, in contrast, hypsochomically 
shifted (Figure 3). All visible region features showed a weaker lower energy shoulder 
that extended to ca. 600 nm in these complexes. For related iridium(III) complexes 
this observation has been previously attributed to the transition to the spin forbidden 
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3MLCT state. Further discussion of the nature of these electronic transitions is 
provided below. 
 The electrochemical characteristics of the complexes were studied in de-
oxygenated dichloromethane. The cyclic voltammograms were measured using a 
platinum disc electrode (scan rate υ = 200 mV s-1, 1 × 10-3 M solutions, 0.1 M 
[NBu4][PF6] as a supporting electrolyte). Each complex showed an irreversible 
oxidation process between +1.4 and +1.6 V, which is assigned to a Ir3+/4+ process. 
The methyl-substituted complexes of L1, L2 and L5 possessed the lowest Eox values 
consistent with the anticipated electron donating ability of the quinoxaline ligands. An 
irreversible signal around -0.9 V was also observed and is assigned to a ligand-centred 
reduction. 
 
<Figure 3> 
 
Density functional theory 
Figure S8 (ESI) illustrates the Kohn-Sham frontier orbitals for complex 
[Ir(L1)2(bpy)]PF6 in chloroform. The orbitals are shown at the minimum energy 
geometry on the S0 surface. The orbitals illustrate that the occupied molecular orbitals 
(MO) have strong Ir(5d) character, whereas the unoccupied orbitals are more ligand 
centred. This is confirmed through MO decomposition analysis (see Table S4, ESI, 
GaussSum Package17): the highest occupied molecular orbital (HOMO) has equal MO 
contributions from the metal (33%) and the two identical quinoxaline ligands (33% and 
33%), with a negligible contribution from the bipyridine (1%). In contrast, the lowest 
unoccupied molecular orbital (LUMO) is predominantly centred on the quinoxalines 
(48% and 47%). All complexes exhibit similar orbital contributions, however [Ir(L5-
L7)2(bpy)]PF6 have slightly reduced metal contributions to the HOMO, between 28% 
and 30%. The contributions from the quinoxaline ligands are necessarily near 
degenerate given the symmetric nature of the system. These orbital descriptions 
afford further analysis of the excited states of this system. TD-DFT calculations 
suggest the character of all the singlet excited states (that lie in a region of interest, 
250 nm < l < 750 nm) are reasonably mixed, however most of the occupied MOs have 
sizeable Ir(5d) contributions, the HOMO-1 being the notable exception, and all the 
unoccupied orbitals ligand centred, with  
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< 5% metal contributions, therefore each state will possess a significant degree of 
1MLCT character.  The longest wavelength singlet excitation is predicted to be at l = 
405 nm, and does not account for the broad structureless feature observed in the 
absorption spectrum with lmax ≈ 475 nm, typically attributed to the formally spin 
forbidden T1 ¬ S0, which may become weakly allowed due to spin-orbit effects. This 
is in reasonable agreement with the comparison between the energy of the T1 state at 
the geometry of the S0 ground state minimum, which corresponds to a predicted 
3MLCT band at l =  514 nm. These transitions all compare qualitatively favourably 
with the observed UV-vis. spectrum of [Ir(L1)2(bpy)]PF6, as shown in Figure 4. 
Optimization of triplet [Ir(L1)2(bpy)]PF6, affords an examination of the spin-
forbidden emission bands of the complex. This procedure leads to a significant 
underestimation of the energy of the spin forbidden band: the computed vertical 
transition occurs at 719 nm, with the experimental observation of this band (lmax ≈ 630 
nm). This observation could be attributed to the evolution of the system from an initially 
prepared singlet photoexcited state into a higher lying triplet state from which emission 
occurs (TD-DFT calculations suggest, for example, that there are three additional 
triplet states within 0.3 eV of T1 within the Franck-Condon region). However, Kasha’s 
rule would suggest that 3MLCT emission occurs after photoexcitation at the S0 
minimum energy geometry; whereupon it is assumed the ISC, IC and IVR processes 
occur rapidly in the excited states, such that phosphorescence occurs from the relaxed 
T1 geometry. The T1 geometry relaxation primarily involves additional buckling of a 
single quinoxaline ligand, and a more subtle change in the bipyridine.   
 Despite the relatively subtle changes in the triplet state geometry, these complexes 
exhibit a range of low frequency vibrational modes, leading to a very broad Franck-
Condon envelope for these electronic transitions. A cursory investigation of the 
emission band profile of [Ir(L1)2(bpy)]PF6 at 298 K, utilizing the Franck-Condon 
procedures in the Gaussian 09 suite,18 exclusive of Herzberg-Teller interactions, 
shows that indeed the emission profile will be broad, and spans the wavelength region 
over which phosphorescence is observed, leading to the conclusion that emission is 
indeed observed from T1. Such a methodology is quantitatively problematic for system 
of this size and with such a number of low frequency vibrational modes, but provides 
a qualitative depiction of the complex emission. As shown in Figure S9 (ESI), this 
simulation provides good agreement with the experimentally recorded emission band, 
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reasonably well reproducing both the lmax value, and the band contour. From the 
simulation it can be extracted that the band profile is predominantly formed by a 
progression in mixed C-C stretch/C-C-C bend modes localized on the quinoxaline 
ligands (~1400 cm-1). This is in good agreement with the electron density change 
induced by the 3MLCT emission. These vibronic features are broadened by multiple 
combinations of low frequency modes. In addition, the calculations illustrate the 
adiabatic transition values are a more appropriate model of emission band positions 
(Table 2). These data illustrate that the dichloro –complexes exhibit substantial 
bathochromic shifts, in good agreement with experiment. 
 
<Figure 4> 
 
A more complete investigation of the vibronic band shapes and Franck-Condon effects 
was performed on the S1/T1 ¬ S0 computed spectral features for [Ir(L1)2(bpy)]PF6. 
Photoabsorption cross sections were computed by sampling over the ground state 
(S0) geometries accessible at room temperature using a nuclear ensemble method, 
implemented in the Newton-X computational suite.19,20 In this case, 2000 geometries 
(Ns) were sampled from an uncoupled harmonic oscillator Wigner distribution such 
that they describe a ground state (S0) quantum distribution, with excitation energies 
(E0n) and oscillator strengths (f0n) for the first ten singlet states (Nn) and first 5 triplet 
states, computed at each geometry (Rk), and then summed (with a d = 0.2 eV 
Lorentzian convolution [red]) to construct the photoabsorption cross section (s(E)). 
 This methodology can be used to provide band shapes and relative cross 
sections for electronic transitions, but unlike the Franck-Condon method described 
above, does not reproduce vibronic progressions. It is worth noting the refractive index 
for all calculations is assumed to be 1. This assessment of band shapes is extremely 
computationally costly and has only been applied to [Ir(L1)2(bpy)]PF6, in order to 
demonstrate the accuracy of the band assignments. 
 
𝜎 𝐸 = 𝜋𝑒&𝛾2𝑚𝑐𝜀, 1𝑁/0 𝑓,0 𝑹345
6
3
47
08, 𝑔 𝐸 − 𝐸,/ 𝑹0 , 𝛿  
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Table	2.	Computed	spectral	properties	for	all	complexes	alongside	experimentally	observed	
band	positions	in	parentheses.	The	experimental	spin	allowed	absorption	band	positions	are	
taken	from	the	band	onsets,	whereas	the	spin	forbidden	parameters	are	lmax	values	for	the	
respective	bands.	Shaded	rows	highlight	L5-L7	phenyl	substituted	analogues	of	L2-L4.	
Both	vertical	and	adiabatic	emission	energies	are	reported,	the	latter	in	italics.	
	
 
Compound[a] S1 ←S0 (nm) [a] T1 ←S0 (nm) [b] T1 → S0 (nm) [b] 
[Ir(L1)2(bpy)]PF6 405 (372) 541 (477) 691, 607 (627) 
[Ir(L2)2(bpy)]PF6 402 (402) 533 (474) 698, 605 (617) 
[Ir(L3)2(bpy)]PF6 419 (406) 565 (500) 708, 630 (634) 
[Ir(L4)2(bpy)]PF6 409 (394) 552 (480) 692, 612 (624) 
[Ir(L5)2(bpy)]PF6 406 (417) 540 (479) 723, 618 (624) 
[Ir(L6)2(bpy)]PF6 423 (428) 572 (501) 730, 642 (645) 
[Ir(L7)2(bpy)]PF6 414 (418) 555 (483) 716, 626 (632) 
[a] Recorded in chloroform. [b] In chloroform, lex = 355 nm 
 
Given the remarkable agreement between the absorption spectrum of 
[Ir(L1)2(bpy)]PF6 and the computational spectral simulation, the relative band 
positions of all the complexes have been computed, and are displayed in Table 2. 
 
<Figure 5> 
 
Table	3.	Emission	data	of	the	complexes	recorded	in	chloroform.	Shaded	rows	highlight	L5-L7	
phenyl	substituted	analogues	of	L2-L4.	
	
Compound lem /  
nm a,b 
τ  /  
µs a,c Φem
 a kr / s
-1  
´105 
knr / s-1  
´106 
[Ir(L1)2(bpy)]PF6 627 0.46 5.7 1.2 2.1 
[Ir(L2)2(bpy)]PF6 617 0.45 5.1 1.1 2.1 
[Ir(L3)2(bpy)]PF6 634 0.34 1.8 0.32 2.9 
[Ir(L4)2(bpy)]PF6 624 0.40 6.0 1.5 2.4 
[Ir(L5)2(bpy)]PF6 624 0.44 6.6 1.5 2.1 
[Ir(L6)2(bpy)]PF6 645 0.31 6.4 2.1 3.0 
[Ir(L7)2(bpy)]PF6 632 0.54 7.8 1.4 1.1 
a In chloroform; b In chloroform, lex = 480 nm; c Luminescence lifetime in chloroform, lex = 459 nm; d Quantum yield with [Ru(bpy)3][PF6]2 as standard 
(ΦΔ = 0.018 in acetonitrile).21  
 
The complexes showed emission properties in the visible region (Figure 5). Steady 
state measurements in both chloroform (Table 3) and toluene (Table 4) confirmed that 
the complexes emit with a broad feature at 550-750 nm. The coordinated quinoxaline 
ligands modulate the emission energy of the complexes with the trimethylated species 
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[Ir(L2)2(bpy)]PF6 revealing the highest energy emission, and the dichloro- analogues 
displaying the most bathochromic shift within the series. The shift to longer wavelength 
upon chlorination is a result of changing electronic character of the system, 
demonstrated clearly by the reproducibility of this trend in the T1 ←S0 TD-DFT 
calculations (Table 2), and equally borne out by the shift in S1 ←S0 band onsets. 
However, the cause of the reduced emission lifetimes for the chlorinated species 
cannot be deconvoluted from a mixture of electronic and relativistic effects, and indeed 
an increase in ISC rates (supported by increased knr contributions) may be anticipated 
for the dichloro- species.  
 In order to validate the hypothesis that chlorine substitution of the quinoxaline 
ligands leads to an increase S0/T1 spin orbit couplings (SOC), SOC elements have 
been computed from LR-TDDFT calculations at the T1 minimum energy geometries 
for [Ir(L1)2(bpy)]PF6 and [Ir(L6)2(bpy)]PF6. Values are generated utilising a Breit-
Pauli SO operator based approach, recently implemented in the PySOC 
computational suite. These calculations suggest that the SOC elements, < S0 | HSO | 
T1 >, evaluated as the root of the squared sum of the ms sublevels, is larger (5%, 149 
cm-1 vs 142 cm-1) for the chlorinated [Ir(L6)2(bpy)]PF6 than for [Ir(L1)2(bpy)]PF6. This 
change is characteristic of a reduced T1 lifetime for the chloro-substituted systems, 
and along with the electronic shift in the potential energy surfaces, serves to explain 
the photophysics of the molecule. 
 Experimental time-resolved luminescence lifetime measurements showed 
monoexponential decay character in each case, consistent with a single emitting state. 
These observed lifetimes confirmed the phosphorescent nature of the emission for all 
complexes, and corresponding degassed measurements indicated sensitivity to 
quenching via 3O2, with lifetimes typically extending into the microsecond domain. 
Thus, all the photophysical data are consistent with an emitting state that possesses 
significant 3MLCT character. 
 
Transient absorption spectroscopy 
Transient absorption (TA) spectroscopy was carried out on each of the complexes 
using chloroform solutions. All the spectra are similar in appearance, and once again 
complex [Ir(L1)2(bpy)]PF6 is chosen as an example for further discussion. The 
spectrum shown in Figure 6 is illustrative of TA spectra for all of the complexes 
described herein. From short to long wavelength, the spectrum shows a ground state 
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bleach (negative DOD) at l = 355 nm, two features corresponding to putative triplet-
triplet absorptions in the visible (lmax ≈ 430 nm and 560 nm, respectively) and finally 
a long wavelength emission attributed to the spin-forbidden T1 → S0 radiative 
transition. The two triplet absorption bands are consistent with TD-DFT calculations 
which suggests that there are a set of strong Tn ¬T1 absorption bands at l < 600 nm. 
The longest wavelength, negative-going peak is assigned based on the similarity 
between the TA feature (black) and the emission profile (red). 
 
<Figure 6> 
 
Each feature, including the ground state bleach and recovery, and the 
phosphorescence, exhibit similar TA lifetimes (right of figure 6), suggesting that each 
peak relates to the same photoexcitation, intersystem crossing (ISC) process and 
deactivation. This is attributed to the formation of the lowest triplet state, via prompt 
S1/T1 ISC and compare relatively well to the observed lifetime from time-resolved 
emission measurements.22 Figure 7 displays a comparison of transient absorption 
spectra for the complexes [Ir(L1)2(bpy)]PF6, [Ir(L5)2(bpy)]PF6 and [Ir(L6)2(bpy)]PF6. 
Each spectrum shows qualitatively similar features, with the exception of the ground 
state bleach <450 nm, which appears to be a clear doublet in the case of 
[Ir(L5)2(bpy)]PF6  and [Ir(L6)2(bpy)]PF6, but does not show the same spectral shape 
for [Ir(L1)2(bpy)]PF6. For each of the complexes the temporal evolution (Fig. 8) of the 
four transient absorption features described in Figure 7 have been analysed in an 
analogous fashion and are shown in Table S5 (ESI), alongside the spin-forbidden 
emission lifetimes, duplicated from Table 2. 
 
<Figure 7> 
 
<Figure 8> 
 
TTA upconversion measurements 
TTA upconversion luminescence experiments were conducted in degassed toluene 
using the complexes as the donor component and 9,10-diphenylanthracene (DPA) as 
the acceptor. The spectra in Figure 9 show the recorded emission spectra in degassed 
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toluene for these upconversion experiments. In each case the graphs contain 
superimposed emission profiles for the native complex and the complex/DPA mixture 
following excitation at 510 nm. The DPA triplet excited state is at 700 nm (1.77 eV) 
and therefore lies below the triplet emitting level of all of the complexes in the series. 
Direct irradiation of DPA using 510 nm does not produce any emission.  In contrast, 
for the majority of the complex/DPA mixtures, fluorescence from DPA was observed 
at 400-500 nm which is therefore indicative of an upconversion process. This was 
most pronounced for [Ir(L1)2(bpy)]PF6, [Ir(L2)2(bpy)]PF6 and [Ir(L5)2(bpy)]PF6 which 
display a concomitant quenching of the 3MLCT emission band at  
600-700 nm. 
 
<Figure 9> 
 
These observations were quantitatively supported by the measured quantum yields 
for upconversion (Table 4) which showed significant variation across the series of 
complexes. Interestingly, the methylated variants performed best, amongst which 
[Ir(L1)2(bpy)]PF6 and [Ir(L2)2(bpy)]PF6 displayed remarkable efficiencies of 26% and 
39%, respectively. The latter is the highest recorded value for TTA upconversion with 
a triplet sensitiser. 
 
<Figure 10> 
 
In comparison, the upconversion performance was contrastingly low (£ 1%) for both 
dichloro-species [Ir(L3)2(bpy)]PF6 and [Ir(L6)2(bpy)]PF6. Previous reports in the 
literature have highlighted high molar absorption coefficients in the visible region and 
long triplet excited state lifetimes as advantageous attributes for triplet sensitizers.23  
It is notable that these complexes possess modest triplet state lifetimes and molar 
absorption values around 5000 M-1cm-1 in the visible region at ca. 500 nm. The 
luminescence data in toluene revealed a larger variation in emission properties with 
the methylated variants displaying the highest emission energies and the longest 
triplet state lifetimes. The poorly performing dichloro- derivatives show the longest 
wavelength emission maxima and shortest triplet lifetimes. The difluoro-substituted 
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complexes perform slightly better than the dichloro analogues, probably reflecting the 
longer triplet lifetime values. 
 
Table 4. Emission and upconversion data of the complexes recorded in toluene. 
Shaded rows highlight L5-L7 phenyl substituted analogues of L2-L4. 
 
Compound lem /  
nm a,b 
tobs / µsb tobs / µs c ΦUC / 
%d 
[Ir(L1)2(bpy)]PF6 618 0.41 2.2 25.9 
[Ir(L2)2(bpy)]PF6 609 0.38 2.3 39.3 
[Ir(L3)2(bpy)]PF6 656 0.38 0.8 0.1 
[Ir(L4)2(bpy)]PF6 638 0.39 1.8 2.0 
[Ir(L5)2(bpy)]PF6 617 0.37 2.0 9.6 
[Ir(L6)2(bpy)]PF6 660 0.35 1.8 1.0 
[Ir(L7)2(bpy)]PF6 646 0.38 1.3 4.0 
 
[a] In toluene (1.0 × 10−5 M); [b] Luminescence lifetime in air, lex = 510 nm; [c] Luminescence lifetime in deaerated toluene, lex = 510 nm; [d] TTA 
upconversion quantum yield (ΦUC) with diiodo-Bodipy as standard (ΦF = 0.027 in acetonitrile). 
 
 
The visual representation of the upconversion was photographically recorded for the 
best performing methylated complexes and is shown in Figure 10. The variation in 
visual appearance can be plotted using CIE coordinates (Fig. 11) and conveniently 
demonstrates the tuneability of the system. The observed red emission of the parent 
triplet sensitizers is dramatically shifted upon addition of DPA to give new CIE 
coordinates. 
 
<Figure 11>  
 
Conclusions 
The use of substituted quinoxaline ligands as cyclometalating units for iridium(III) has 
proven to be a highly efficient route towards the development of high performance 
sensitizers for triplet-triplet annihilation upconversion. Methylation of the coordinated 
quinoxaline heterocycle increases the energy and the lifetime of the triplet state 
emission and thus enhances performance. In contrast, whilst chloro-substitution 
bathochromically shifts the absorption and emission profiles, the dramatic reduction in 
triplet state lifetime for the complex of L3 proves unfavourable with respect to TTA 
upconversion efficiency. We attribute this, with supporting calculations, to the 
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enhancement in ISC assisted by the chlorine substituents that leads to more rapid 
non-radiative deactivation of the 3MLCT state. 
 
Experimental Section 
X-ray crystallography 
Suitable crystals for [Ir(L2)2(bpy)]PF6, [Ir(L5)2(bpy)]PF6 and [Ir(L7)2(bpy)]PF6 were 
obtained and mounted on a MITIGEN holder in perfluoroether oil on a Rigaku FRE+ 
equipped with either VHF Varimax confocal mirrors and an AFC12 goniometer and 
HyPix 6000 detector diffractometer ([Ir(L5)2(bpy)]PF6) or HF Varimax confocal mirrors 
and an AFC12 goniometer and HG Saturn 724+ detector diffractometer 
([Ir(L2)2(bpy)]PF6 and [Ir(L7)2(bpy)]PF6).24 The crystal was kept at T = 100(2) K 
during data collection. Using Olex225 the structure was solved with the ShelXT 26 
structure solution program, using the Intrinsic Phasing solution method. The model 
was refined with version 2014/7 of ShelXL27 using Least Squares minimisation. All 
non-H atoms were refined anisotropically and difference Fourier syntheses were 
employed in positioning idealized hydrogen atoms and were allowed to ride on their 
parent C-atoms. For sample [Ir(L5)2(bpy)]PF6 there was highly disordered solvent 
(assumed to be either MeCN, ether or a mixture) that could not be suitably modelled. 
As such solvent masking within Olex2 was applied. Due to the quality of the crystals 
for sample [Ir(L7)2(bpy)]PF6 a significant number of restraints (RIGU, SADI, BUMP) 
were required.  
Computational methods 
Electronic structure calculations were all performed using density fitted-density 
functional theory within the Gaussian 09 computational chemistry suite.vi All 
calculations were performed using the Stuttgart-Dresden (SDD) effective core 
potential and basis set in the treatment of the iridium, in combination with a 6-31G* 
basis set for all other light atoms. Full geometry optimizations were performed for the 
cationic complexes utilizing the self-consistent reaction field model (SCRF) which 
treats the solvent implicitly as a dielectric continuum. In all cases the solvent chosen 
was chloroform, consistent with that utilized in the both final synthesis and in the 
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majority of the spectroscopic measurements. Chloroform is characterized by an 
electrical permittivity of ε = 4.7113 within the calculations. This computational method 
models the solvent as surrounding a cavity in which the solute resides, and this cavity 
is characterized using an integral equation formalism for the polarizable continuum 
model (IEFPCM). This model represents the system in equilibrium during, for example, 
an optimization routine: in all excited state calculations a non-equilibrium solvent 
model is used. 
All geometry optimizations were performed using an ultrafine grid and very tight 
convergence criteria, and the minima were confirmed as stationary points through the 
computation of harmonic vibrational frequencies, each of which showed no imaginary 
components. These stationary points were used in single point TD-DFT calculations 
to compute vertical excitation energies. All TD-DFT calculations were undertaken 
using a linear response approach. All TD-DFT calculations were also performed with 
a long range corrected hybrid functional (CAM-B3LYP). 
Phosphorescence and spin-forbidden absorption bands were investigated using 
unrestricted density functional theory to compute parameters associated with the first 
triplet state (T1), using an identical methodology as for the singlet states. 
Decomposition of the molecular orbital character was performed using the GaussSum 
software package. Crystal structure overlays with optimised computational structures 
has been performed using the Chimera software package, which has also been used 
to calculate root mean squared deviation (RMSD) values for these comparative 
structures.28 
Transient absorption measurements 
Transient absorption measurements were carried out using an Edinburgh Instruments 
LP920 spectrometer. All spectra were collected using a pump wavelength of 355 nm 
(third harmonic of a Continuum Surelite II Nd:YAG laser system). The probe light for 
these measurements was a Xenon lamp, affording spectral generation between 300 
< l < 800 nm. Wavelength dependent spectra were recorded with a 2.05 nm spectral 
resolution,  collected using an Andor ICCD camera, and integrated over the first 500 
ns after the pump laser pulse. The spectra are presented as DODXe lamp, which is simply 
referred to as DOD. Lifetime data was generated using a photomultiplier to collect time 
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resolved signals, with the bandwidth of these data being identical to the camera 
resolution (2.05 nm). The lifetime data is fit using the Origin 2017 software package, 
and each data set is fit using a monoexponential function, with no evidence of 
multiexponential components. Uncertainties in lifetimes are taken from the Least-
Squares fitting algorithm, and are not indicative of the uncertainties in multiple fits or 
data sets. 
Cyclic voltammetry 
Electrochemical studies were carried out using a Parstat 2273 potentiostat in 
conjunction with a three-electrode cell. The auxiliary electrode was a platinum wire 
and the working electrode a platinum (1.0 mm diameter) disc. The reference was a 
silver wire separated from the test solution by a fine porosity frit and an agar bridge 
saturated with KCl. Solutions (10 ml CH2Cl2) were 1.0 × 10-3 mol dm-3 in the test 
compound and 0.1 mol dm-3 in [NBun4][PF6] as the supporting electrolyte. Under these 
conditions, E0′ for the one-electron oxidation of [Fe(η-C5H5)2], added to the test 
solutions as an internal calibrant, is +0.46 V. [36] Unless specified, all electrochemical 
values are at υ = 200 mV s-1. 
Triplet-Triplet Annihilation Upconversion 
Associated luminescence spectra were recorded on Shimadzu RF-5301PC 
spectrofluorometer. The fluorescence and phosphorescence lifetimes were measured 
on an OB920 fluorescence/phosphorescence lifetime instrument (Edinburgh, U.K.) 
with an EPL picosecond pulsed diode laser (510 nm ± 10 nm, pulse width: 119.9 ps, 
maximum average power: 5 mW; All compounds in flash photolysis experiments were 
deaerated with N2 for ca. 10 min and the gas was maintained during the measurement.  
Continuous laser (510 nm) was used for upconversion and the power of the laser 
beam was 5.2 mW. The diameter of the spot of the 510 nm laser was ca. 3 mm. The 
mixed solution (with different triplet sensitizers and acceptor) was deaerated for 10 
min before experiment, and the gas flow was kept during the measurement. The 
upconverted fluorescence was recorded with a RF 5301PC spectrofluorometer. In 
order to repress the laser scattering, a small black box was put behind the fluorescent 
cuvette as beam dump to trap the laser. 
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The upconversion quantum yields (FUC) of all the complexes in toluene were using the 
fluorescence quantum yield of diiodoBodipy (FF = 2.7% in acetonitrile) as the standard 
to be determined. The upconversion quantum yield was using the following equation 
(Eq. 2) to calculate, where F, A, I and h represent the quantum yield, absorbance, 
integrated photoluminescence intensity and the refractive index, respectively. 
Symbols with ‘std’ and 'sam' are the corresponding parameters for the standard used 
in the measurement of quantum yield and samples to be measured.  
 
(Eq. 2) 
Synthesis of 2-methyl-3-phenylquinoxaline, L1  
1-phenyl-1,2-propanedione (2.0 mL, 15 mmol) and 1,2-diaminobenzene (1.60 g, 15 
mmol) were dissolved in ethanol (30 mL) with acetic acid (1 mL). The reaction mixture 
was heated at reflux for 24 hours under a nitrogen atmosphere. The mixture was 
cooled to room temperature and the solvent removed in vacuo. The crude product was 
taken up in dichloromethane (20 mL) and washed with hydrochloric acid (0.1 M, 2 ´ 
20 mL). The organic phase was dried over MgSO4 and dried in vacuo to yield a low 
melting-point, yellow solid (3.26 g, 81 %). 1H NMR (400 MHz; CDCl3): δH 8.10 (1H, d, 
JHH = 8.37 Hz), 8.05 (1H, d, JHH = 8.37 Hz), 7.67-7.75 (3H, m), 7.65 (2H, d, JHH = 7.15 
Hz), 7.44-7.54 (3H, m), 2.77 (3H, s, Me), 2.51 (3H, s, Me) ppm; 13C{1H} NMR (75 MHz, 
CDCl3): dC 155.7, 153.3, 142.0, 141.7, 139.8, 130.5, 130.0, 129.8, 129.7, 129.3, 129.1, 
25.2 ppm. LR MS found m/z 220.1072, calcd m/z 220.1073 for C15H12N2. UV-vis. 
(CHCl3) lmax (ε / dm3mol-1cm-1):  325 (9400) nm. IR (solid) u / cm-1 : 3061, 3032, 2961, 
1952, 1813, 1686, 1611, 1578, 1557, 1508, 1495, 1483, 1443, 1431, 1395, 1375, 
1341, 1248, 1217, 1188, 1132, 1117, 1074, 1030, 1005, 993, 974, 950, 921, 897, 868, 
818, 797, 708, 679, 619, 608, 575, 559, 496, 467, 436, 409, 401. 
Synthesis of L2  
As L1 but with 1-phenyl-1,2-propanedione (246 mg, 1.7 mmol) and 1,2-diamino-4,5-
dimethylbenzene (250 mg, 1.8 mmol). Product collected as a low melting-point, brown 
solid. (361 mg, 86 %). 1H NMR (300 MHz, CDCl3): dH 7.85 (s, 1H), 7.80 (s, 1H), 7.64 
– 7.62 (m, 2H), 7.53 – 7.44 (m, 3H), 2.74 (s, 3H, Me), 2.50 (s, 3H, Me), 2.48 (s, 3H) 
std
sam
2
sam sam
std UC
std std
1 10Φ 2Φ
1 10
A
A
I
I
h
h
-
-
æ öæ öæ ö-
= ç ÷ç ÷ç ÷-è øè øè ø
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ppm; 13C{1H} NMR (101 MHz, CDCl3): dC 153.92, 151.29, 140.27, 139.97, 139.62, 
139.32, 128.97, 128.76, 128.49, 128.28, 127.33, 24.20, 20.44, 20.34 ppm. HRMS 
found m/z 249.1385, calcd m/z 249.1386 for C17H16N2. UV-vis. (CHCl3) lmax (ε / 
dm3mol-1cm-1): 339 (11200), 269 (11400), 262 (21800) nm. IR (solid) u / cm-1 : 3060, 
3030, 2961, 1654, 1483, 1445, 1398, 1373, 1337, 1252, 1217, 1204, 1157, 1123, 
1076, 1024, 1003, 988, 920, 876, 870, 858, 785, 768, 739, 706, 696, 644, 629, 610, 
559, 532, 494, 478, 440, 420, 403. 
Synthesis of L3  
As L1 but with 1-phenyl-1,2-propanedione (190 mg, 1.3 mmol) and 1,2-diamino-4,5-
dichlorobenzene (250 mg, 1.4 mmol). Upon cooling to room temperature, a white 
precipitate formed and was collected by filtration. The precipitate was washed with 
methanol to yield the product as a white solid. (283 mg, 73 %). 1H NMR (300 MHz, 
CDCl3): dH 8.22 (s, 1H), 8.17 (s, 1H), 7.66 – 7.62 (m, 2H), 7.58 – 7.52 (m, 3H), 2.77 
(s, 3H) ppm; 13C{1H} NMR (75 MHz, CDCl3): δC 155.92, 154.01, 139.97, 139.77, 
138.27, 133.69, 129.47, 129.12, 128.91, 128.69, 109.99, 24.54 ppm. HRMS found m/z 
291.0268, calcd m/z 291.0264 for C15H10Cl2N2. UV-vis. (CHCl3) lmax (ε / dm3mol-1cm-
1): 342 (12800), 268 (30700) nm. IR (solid) u / cm-1 : 3088, 1753, 1697, 1587, 1543, 
1491, 1441, 1412, 1389, 1371, 1325, 1246, 1209, 1180, 1169, 1107, 1078, 1022, 
1005, 993, 976, 955, 930, 897, 878, 845, 795, 768, 748, 706, 658, 635, 629, 613, 594, 
550, 509, 490, 461, 428, 417. 
Synthesis of L4 
As for L1 but with 1-phenyl-1,2-propanedione (230 mg, 1.6 mmol) and 1,2-diamino-
4,5-difluorobenzene (250 mg, 1.7 mmol). Upon cooling to room temperature, a white 
precipitate formed and was collected by filtration and washed with methanol. Product 
collected as a white solid. (225 mg, 55 %). 1H NMR (300 MHz, CDCl3): dH 7.87 – 7.77 
(m, 2H), 7.65 – 7.62 (m, 2H), 7.56 – 7.49 (m, 3H), 2.76 (s, 3H) ppm; 13C{1H} NMR (101 
MHz, CDCl3): dC 138.44, 129.29, 128.88, 128.66, 114.78, 114.03, 24.29 ppm; 19F {1H} 
NMR (376 MHz, CDCl3): δF -130.38 (d, 3JFF = 21.2 Hz), -131.17 (d, 3JFF = 21.2 Hz) 
ppm.  HRMS found m/z 257.0888, calcd m/z 257.0885. UV-vis. (CHCl3) lmax (ε / 
dm3mol-1cm-1): 326 (13000) nm. IR (solid) u / cm-1 : 3030, 1630, 1572, 1553, 1497, 
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1450, 1373, 1356, 1339, 1256, 1227, 1200, 1142, 1078, 1015, 1005, 988, 928, 897, 
874, 866, 791, 772, 752, 712, 706, 667, 619, 611, 584, 544, 484, 447, 419, 405. 
Synthesis of L5 
Benzil (357 mg, 1.7 mmol) and 1,2-diamino-4,5-dimethylbenzene (250 mg, 1.8 mmol) 
were dissolved in ethanol (15 mL) and acetic acid (1 mL). The reaction mixture was 
heated at reflux under a nitrogen atmosphere for 24 hours. The mixture was then 
cooled to room temperature and a white precipitate was collected by filtration and 
washed with methanol. (413 mg, 78 %). 1H NMR (300 MHz, CDCl3): dH 7.92 (s, 2H), 
7.51 – 7.48 (m, 4H), 7.35 – 7.31 (m, 6H), 2.49 (s, 6H, Me) ppm; 13C{1H} NMR (75 MHz, 
CDCl3): dC 152.50, 140.55, 140.21, 139.37, 129.84, 128.53, 128.21, 109.99, 20.50 
ppm. HRMS found m/z 311.1542, calcd m/z 311.1543 for C22H18N2. UV-vis. (CHCl3) 
lmax (ε / dm3mol-1cm-1): 356 (13900), 281 (24600), 269 (31800), 254 (44900) nm. IR 
(solid) u / cm-1 : 2974, 1749, 1549, 1531, 1493, 1474, 1460, 1445, 1416, 1400, 1375, 
1346, 1335, 1263, 1211, 1179, 1153, 1074, 1059, 1022, 1003, 966, 932, 870, 849, 
814, 783, 773, 762, 741, 725, 691, 633, 608, 598, 556, 530, 519, 492, 476, 436, 413. 
Synthesis of L6 
As L5 but with benzil (273 mg, 1.3 mmol) and 1,2-diamino-4,5-dichlorobenzene (250 
mg, 1.4 mmol). Product collected as a white solid. (367 mg, 80 %). 1H NMR (300 MHz, 
CDCl3): dH 8.29 (s, 2H), 7.52 – 7.49 (m, 4H), 7.37 – 7.35 (m, 6H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3): dC 154.49, 139.95, 138.39, 134.43, 129.80, 129.29, 128.37 ppm. 
HRMS found m/z 351.0450, calcd m/z 351.0450 for C20H12Cl2N2. UV-vis. (CHCl3) lmax 
(ε / dm3mol-1cm-1): 362 (19400), 254 (61300) nm. IR (solid) u / cm-1 : 3067, 3024, 2980, 
1589, 1535, 1491, 1452, 1439, 1393, 1337, 1254, 1190, 1109, 1074, 1061, 1020, 999, 
964, 920, 883, 874, 831, 814, 766, 733, 719, 692, 640, 621, 606, 598, 546, 511, 488, 
480, 444, 426, 419, 409. 
Synthesis of L7 
As L5, but with benzil (336 mg, 1.6 mmol) and 1,2-diamino-4,5-difluorobenzene (250 
mg, 1.7 mmol). Product collected as an orange solid. (296 mg, 58 %). 1H NMR (300 
MHz, CDCl3): dH 7.91 (app. td, J = 1.37, 9.35 Hz, 2H), 7.51 – 7.48 (m, 4H), 7.41 – 7.31 
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(m, 6H) ppm; 13C{1H} NMR (75 MHz, CDCl3): dC 154.31, 154.07, 153.69, 150.89, 
150.66, 138.51, 138.48, 129.77, 129.13, 128.37, 114.72 ppm; 19F{1H} NMR (376 MHz, 
CDCl3): δF -129.86 ppm. HRMS found m/z 319.1044, calcd m/z 319.1041 for 
C20H12F2N2. UV-vis. (CHCl3) lmax (ε / dm3mol-1cm-1): 343 (14900), 261 (16800) nm. IR 
(solid) u / cm-1 : 3051, 1597, 1568, 1541, 1456, 1435, 1352, 1342, 1246, 1217, 1194, 
1175, 1152, 1142, 1082, 1072, 1055, 1022, 1001, 972, 939, 918, 872, 818, 785, 772, 
760, 752, 719, 700, 677, 623, 610, 573, 542, 521, 498, 438, 424, 419. 
Complex Synthesis 
IrCl3.xH2O (1 eq.) and ligand, L (2 eq.) were dissolved in 2-ethoxyethanol (10 mL) and 
the reaction mixture heated at reflux for 48 hours. The reaction was then cooled to 
room temperature and water (30 mL) was added to form a dark brown precipitate. The 
solid was collected by filtration and assumed to yield [Ir(L)2μ-Cl]2 and used without 
further purification. 
 
Synthesis of [Ir(L1)2(bpy)]PF6  
[Ir(L1)2μ-Cl]2 (100 mg, 0.075 mmol) and 2,2¢-bipyridyl (0.025 g, 0.16 mmol) were 
dissolved in 2-ethoxyethanol (10 mL) and heated at reflux for 24 hours under a 
nitrogen atmosphere. The reaction mixture was then cooled to room temperature and 
a saturated solution of aqueous ammonium hexafluorophosphate was added. Upon 
formation of a red precipitate, the mixture was filtered and the precipitate washed with 
water and diethyl ether to yield the product as a red solid. (0.08g, 68 %). 1H NMR 
(300MHz, CDCl3): δ H 8.39 (2H, d, JHH = 8.31 Hz), 8.24 (2H, d, JHH = 8.31 Hz), 8.17 
(2H, d, JHH = 5.32 Hz), 8.01 (2H, app.t, JHH = 7.86 Hz), 7.90 (2H, d, JHH = 8.31 Hz), 
7.45-7.57 (4H, m), 7.16-7.24 (2H, m), 7.00 (2H, app.t, JHH = 7.69 Hz), 6.86 (2H, app. 
t, JHH = 7.69 Hz), 6.61 (2H, d, JHH = 7.60 Hz), 3.36 (6H, s, Me) ppm; 13C{1H} NMR 
(400MHz, CDCl3): δC 163.7, 155.1, 152.6, 152.0, 146.6, 144.0, 140.4, 140.0, 139.7, 
135.1, 130.9, 130.5, 130.4, 130.1, 129.2, 127.6, 124.8, 123.6, 123.2, 27.5 ppm. HRMS 
found m/z 787.2148, calcd m/z 787.2158 for C40H30IrN6. UV-vis. (CHCl3): λmax/nm (ε / 
dm3mol-1cm-1): 477 (2500), 372 (13200), 253 (27900) nm. IR (solid) u / cm-1 : 1605, 
1578, 1530, 1449, 1427, 1387, 1348, 1261, 1215, 1196, 1165, 1130, 1016, 1001, 897, 
837, 770, 750, 731, 704, 660, 627, 592, 557, 459, 420, 415, 405. 
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Synthesis of [Ir(L2)2(bpy)]PF6 
Product collected as a red solid (133 mg, 94 %). 1H NMR: (400 MHz, Acetone-d6): δH 
8.57 – 8.54 (2 H, m), 8.49 (2 H, dd, JHH = 8.3, 1.2 Hz), 8.41 (2 H, app. dt, JHH = 8.2, 
1.0Hz), 8.16 (2 H, ddd, JHH = 8.3, 7.6, 1.6 Hz), 7.86 – 7.81 (2 H, m), 7.66 (2 H, s), 7.24 
(2 H, ddd, JHH = 8.3, 7.1, 1.3 Hz), 7.17 (2 H, s), 6.86 – 6.79 (2 H, m), 6.70 (2 H, dd, 
JHH  = 7.7, 1.3 Hz), 3.34 (6 H, s, Me), 2.30 (6 H, s, Me), 1.81 (6 H, s, Me) ppm; 13C {1H} 
(101 MHz, Acetone-d6): δC 164.56, 156.84, 154.00, 153.38, 149.62, 146.39, 142.69, 
142.14, 141.53, 140.70, 140.05, 136.48, 132.09, 131.63, 130.00, 129.66, 125.61, 
125.24, 124.33, 28.18, 20.36, 20.11 ppm. HRMS found m/z 843.2783 calcd m/z 
843.2784 for C44H38IrN6. UV-vis (CHCl3) lmax (ε / dm3mol-1cm-1):  474 (4800), 391 
(22100), 376 (23900), 309 (19300), 390 (32300), 268 (47200) nm. IR (solid) u / cm-1 : 
1601, 1582, 1560, 1526, 1483, 1445, 1396, 1375, 1342, 1323, 1267, 1219, 1171, 
1134, 1063, 993, 835, 795, 768, 737, 702, 660, 627, 556, 474, 434, 420, 403. 
Synthesis of [Ir(L3)2(bpy)]PF6 
As [Ir(L1)2(bpy)]PF6 but with [Ir(L3)2Cl]2 (100 mg, 0.06 mmol) and 2,2¢-bipyridine (20 
mg, 0.1 mmol). Product collected as a red solid (61 mg, 46 %). 1H NMR (400 MHz, 
Acetone-d6): δH 8.60 (2 H, d, JHH = 8.4), 8.51 (3 H, dd, JHH = 5.6, 3.6), 8.48 (1 H, s), 
8.26 – 8.18 (2 H, m), 8.13 (2 H, d, JHH = 1.2), 7.92 – 7.83 (2 H, m), 7.59 (2 H, s), 7.31 
(2 H, dd, JHH = 8.3, 6.7), 6.97 – 6.89 (2 H, m), 6.86 (1 H, s), 6.84 (1 H, s), 3.41 (6 H, s) 
ppm. 13C {1H} NMR (126 MHz, DMSO): δC 165.56, 155.14, 154.80, 153.75, 147.29, 
143.91, 140.79, 138.80, 138.42, 135.28, 133.16, 132.60, 132.14, 131.53, 129.82, 
129.31, 125.05, 124.96, 123.41, 27.34 ppm. HRMS found m/z 925.0548, calculated 
m/z 925.0558 for C40H26Cl4IrN6. UV-vis. (CHCl3) lmax (ε / dm3mol-1cm-1): 500 (4500), 
383 (23700), 298 (28900), 266 (48200) nm. IR (solid) u / cm-1 : 1603, 1576, 1528, 
1464, 1447, 1381, 1315, 1265, 1188, 1165, 1132, 1113, 1061, 1026, 1009, 962, 895, 
870, 843, 824, 772, 739, 729, 673, 664, 646, 637, 608, 556, 467, 428, 419, 403. 
Synthesis of [Ir(L4)2(bpy)]PF6 
Product collected as a red solid (133 mg, 97 %). 1H NMR (400 MHz, Acetone-d6): δH  
8.58 (2 H, dd, JHH = 8.3, 1.2), 8.54 (2 H, ddd, JHH = 5.5, 1.6, 0.8), 8.47 (2 H, dt, JHH = 
8.2, 1.0), 8.25 – 8.18 (2 H, m), 7.92 – 7.81 (4 H, m), 7.34 – 7.20 (4 H, m), 6.95 – 6.88 
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(2 H, m), 6.84 – 6.79 (2 H, m) ppm. 13C {1H} NMR (101 MHz, Acetone-d6): δ C 155.55, 
152.77, 147.77, 144.41, 140.52, 135.29, 131.51, 131.13, 128.91, 124.79, 123.34 ppm. 
19F NMR (376 MHz, Acetone-d6): δF -72.63 (d, J = 711.7 Hz), -131.73 (d, J = 21.9 Hz), 
-133.10 (d, J = 21.9 Hz) ppm. HRMS found m/z 859.1780, calculated m/z 859.1781 
for C40H26F4IrN6. UV-vis. (CHCl3) lmax (ε / dm3mol-1cm-1): 480 (2400), 375 (13200), 
311(11800), 288 (15400), 262 (25800) nm. IR (solid) u / cm-1 : 1065, 1578, 1533, 1501, 
1447, 1341, 1331, 1252, 1233, 1196, 1128, 1063, 1036, 997, 878, 841, 795, 772, 741, 
731, 689, 660, 638, 586, 557, 476, 451, 428, 422, 407. 
Synthesis of [Ir(L5)2(bpy)]PF6  
As [Ir(L1)2(bpy)]PF6 but with [Ir(L5)2Cl]2 (150 mg, 0.09 mmol) and 2,2¢-bipyridine (29 
mg, 0.2 mmol). Product collected as a red solid (124 mg, 63%). 1H NMR (400 MHz, 
Acetone-d6): δ H 9.10 (2 H, dt, JHH = 5.1, 2.2), 8.61 – 8.52 (2 H, m), 8.34 – 8.25 (2 H, 
m), 8.24 – 8.15 (2 H, m), 7.96 (4 H, dt, JHH = 6.7, 2.7), 7.78 (2 H, s), 7.74 – 7.65 (6 H, 
m), 7.34 (2 H, s), 7.18 (2 H, ddd, JHH = 8.2, 2.9, 1.5), 6.78 – 6.72 (2 H, m), 6.69 – 6.63 
(2 H,m), 6.61 – 6.54 (2 H, m), 2.35 (6 H, s), 1.94 (6 H, s) ppm. 13C {1H} NMR (101 
MHz, Acetone-d6): δ C 162.58, 156.09, 153.60, 152.81, 149.26, 144.93, 142.80, 
141.53, 140.81, 140.42, 139.91, 139.43, 135.23, 131.40, 130.46, 130.06, 129.58, 
129.44, 129.21, 124.84, 123.98, 122.37, 19.43, 18.99 ppm. HRMS found m/z 
967.3086, calcd m/z 967.3099 for C54H42IrN6. UV-vis. (CHCl3) lmax (ε / dm3mol-1cm-1): 
479 (6500), 400 (29300), 362 (24800), 297 (49000), 269 (71300) nm. IR (solid) u / cm-
1: 1603, 1580, 1479, 1447, 1348, 1321, 1234, 1207, 1159, 1134, 1074, 1024, 1001, 
974, 833, 810, 775, 748, 737, 729, 700, 658, 640, 608, 577, 557, 542, 446, 432, 415. 
Synthesis of [Ir(L6)2(bpy)]PF6 
As [Ir(L1)2(bpy)]PF6, but with [Ir(L6)2Cl]2 (100 mg, 0.05 mmol) and 2,2¢-bipyridine (19 
mg, 0.1 mmol). Product collected as a red solid (48 mg, 37 %). 1H NMR (300 MHz, 
Acetone-d6): δH 8.98 (2 H, ddd, JHH = 5.5, 1.7, 0.7), 8.60 (2 H, dt, JHH = 8.2, 1.0), 8.30 
(2 H, td, JHH = 7.9, 1.6), 8.23 – 8.15 (4 H, m), 7.99 – 7.90 (4 H, m), 7.69 (8 H, q, JHH = 
2.2, 1.8), 7.25 – 7.15 (2 H, m), 6.81 – 6.62 (6 H, m) ppm. 13C {1H} NMR (101 MHz, 
Acetone-d6): δ C 166.36, 157.25, 156.93, 155.10, 149.90, 145.27, 142.19, 141.00, 
140.74, 140.57, 136.52, 136.16, 133.44, 132.75, 131.91, 131.67, 130.77, 130.55, 
126.65, 126.43, 123.84 ppm. HRMS found m/z 1049.0839, calculated m/z 1049.0872 
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for C50H30Cl4IrN6. UV-vis. lmax / nm (CHCl3) 501(7300), 404 (35300), 299 (54600), 268 
(87500) nm. IR (solid) u / cm-1: 1603, 1576, 1524, 1493, 1445, 1433, 1406, 1383, 
1342, 1317, 1258, 1186, 1165, 1132, 1115, 1072, 1045, 1026, 1001, 961, 880, 839, 
826, 766, 734, 698, 673, 648, 635, 606, 577, 557, 532, 517, 486, 474, 451, 434, 419. 
Synthesis of [Ir(L7)2(bpy)]PF6 
As [Ir(L1)2(bpy)]PF6 but with [Ir(L7)2Cl]2 (100 mg, 0.06 mmol) and 2,2’-bipyridine (19 
mg, 0.1 mmol). Product collected as a red solid (108 mg, 83 %). 1H NMR (400 MHz, 
Acetone-d6): δ H 9.10 – 9.06 (2 H, m), 8.63 (2 H, d, JHH = 8.2), 8.35 (2 H, tt, JHH = 8.0, 
1.4), 8.22 (2 H, m), 8.01 (6 H, tt, JHH = 8.5, 4.4), 7.79 – 7.68 (6 H, m), 7.55 (1 H, dt, 
JHH = 8.2, 1.5), 7.46 – 7.37 (2 H, m), 7.28 – 7.20 (2 H, m), 6.87 – 6.79 (2 H, m), 6.77 
– 6.72 (2 H, m), 6.69 (2 H, dt, JHH = 7.8, 1.3) ppm. 13C {1H} NMR (101 MHz, Acetone-
d6): δ C 157.50, 150.05, 142.41, 140.79, 136.71, 133.25, 132.55, 131.76, 130.75, 
126.56, 124.00, 117.87 ppm. 19F{1H} NMR (376 MHz, Acetone-d6): δF -72.64 (d, J = 
699.9 Hz), -130.30 (d, J = 21.7 Hz), -132.66 (d, J = 21.7 Hz) ppm. HRMS found m/z 
983.2088, calculated m/z 983.2095 for C50H30F4IrN6. UV-vis. (CHCl3) lmax (ε / dm3mol-
1cm-1): 483 (4500), 396 (21600), 367 (20200), 297 (33100), 265 (48600) nm. IR (solid) 
u / cm-1 : 1603, 1578, 1503, 1447, 1429, 1335, 1275, 1260, 1223, 1204, 1163, 1126, 
1072, 1043, 1026, 980, 874, 835, 810, 758, 739, 700, 660, 640, 623, 615, 557, 536, 
498. 
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Notes	and	references	
‡ CCDC1825271, 1825273 and 1825272 contains supplementary X-ray 
crystallographic data for [Ir(L2)2(bpy)]PF6,  [Ir(L5)2(bpy)]PF6 and [Ir(L7)2(bpy)]PF6 
respectively. This data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/structures/, or from the Cambridge Crystallographic Data 
Centre, Union Road, Cambridge, CB2 1EZ; fax(+44) 1223-336-033 or email: 
deposit@ccdc.cam.ac.uk. 
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Figure 1. X-ray structures of the complexes [Ir(L2)2(bpy)]PF6, [Ir(L5)2(bpy)]PF6 and 
[Ir(L7)2(bpy)]PF6 (top to bottom). Anions and solvents of crystallisation are omitted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Overlay of the crystal structure (blue)  and  
DF-DFT//B3LYP/6-31G*(SDD) optimised structures (brown) for [Ir(L5)2(bpy)]PF6. 
The structures exhibit an RMSD of 0.3 Å. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Absorption spectra of [Ir(L2)2(bpy)]PF6, [Ir(L3)2(bpy)]PF6, 
[Ir(L7)2(bpy)]PF6 (in chloroform). 
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Figure 4. Comparison of the experimental absorption spectrum of [Ir(L1)2(bpy)]PF6 
(black) with the TDDFT//CAM-B3LYP/6-31G*(SDD) convoluted absorption spectrum 
(dashed red), computed the method described in the text.  The red line is a summation 
of spin allowed and spin forbidden transition energies, where all spin forbidden 
transitions are assigned an identical oscillator strength, with the total summative 
transition strength chosen to best illustrate the spectrum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Normalized emission spectra of complexes (in chloroform,  
lex = 355 nm). 
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Figure 6. Left: transient absorption spectrum of [Ir(L1)2(bpy)]PF6 shown in black, 
overlaid with the emission spectrum of the same complex shown in red. Right: 
transient absorption lifetime measurements made at selected wavelengths, 
highlighted as grey bars in the right hand figure. The red traces indicate 
monoexponential fits to these measurements, with corresponding lifetimes displayed 
in each panel. Recorded in chloroform, lex = 355 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Transient absorption spectra of several sample complexes. The spectra 
show qualitatively similar features. Recorded in chloroform,  
lex = 355 nm. 
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Figure 8. Sample time resolved transient absorption data for [Ir(L6)2(bpy)]PF6 prior 
to spectral deconvolution. The data is shown from t = 1800 ns for clarity purposes only. 
 
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 9. Clockwise from top left: the upconversion fluorescence spectra of C1 
[Ir(L1)2(bpy)]PF6, C2 [Ir(L2)2(bpy)]PF6, C7 [Ir(L7)2(bpy)]PF6, and C5 
[Ir(L5)2(bpy)]PF6 as photosensitizer in toluene. DPA (9,10-diphenylanthracene) was 
the acceptor. Excitation was done with a continuous laser at 510 nm (noted as the 
incident peak on the spectra) and power density of 5.2 mW under deaerated 
atmosphere. c (sensitizer) = 1.0 ´ 10-5 M, c (DPA) were 1.6 ´ 10-3 M, 1.6 ´ 10-3 M, 
2.6 ´ 10-4 M, 2.0 ´ 10-4 M, respectively, 20 °C. 
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Figure 10. Photographs of the emission of selected triplet sensitizers C1 
[Ir(L1)2(bpy)]PF6, C2 [Ir(L2)2(bpy)]PF6 and C5 [Ir(L5)2(bpy)]PF6 alone and the 
upconversion with DPA in toluene. Excitation was done with a continuous laser of 510 
nm and power density of 5.2 mW under deaerated atmosphere. c (sensitizers) = 1.0 ´ 
10-5 M; c (DPA) were (a) 1.6 ´ 10-3 M, (b) 1.6 ´ 10-3 M, (c) 2.0 ´ 10-4 M, respectively, 
20 °C. 
 
 
 
 
	
	
	
	
	
	
	
	
	
	
Figure 11. The CIE coordinate changes of triplet sensitizers C1 [Ir(L1)2(bpy)]PF6, C2 
[Ir(L2)2(bpy)]PF6 and C5 [Ir(L5)2(bpy)]PF6 before and after adding DPA. Excitation 
was done with a continuous laser of 510 nm and power density of 5.2 mW under 
deaerated atmosphere. Before: c (Sensitizers) = 1.0 ´ 10-5 M. After: DPA were added 
with 1.6 ´ 10-3 M for C1, 1.6 ´ 10-3 M for C2, 2.0 ´ 10-4 M for C4 and 2.0 ´ 10-4 M for 
C5, respectively, 20 °C. 
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Schemes and captions 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Scheme	1.	Structures	of	the	heteroleptic	Ir(III)	complexes	synthesised	in	the	study	and	the	
generalised	route	to	the	ligands	(top	and	inset).	
	
	
TOC text 
A series of substituted 2-phenylquinoxaline ligands have been explored to finely tune 
the visible emission properties of a corresponding set of cationic, cyclometalated 
iridium(III) complexes.. The complexes were assessed as sensitizers in triplet-triplet 
annihilation upconversion experiments, demonstrating highly impressive 
upconversion quantum yields of up to 39 %. 
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